Patents by Inventor Andre Bachmann

Andre Bachmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions to prevent and treat disorders associated with mutations in the ODC1 gene
    Patent number: 12194010
    Abstract: The invention provides methods for treating or preventing developmental disorders associated with mutations in the OCD1 gene.
    Type: Grant
    Filed: February 2, 2022
    Date of Patent: January 14, 2025
    Assignees: Board of Trustees of Michigan State University, Corewell Health Innovations, LLC
    Inventors: Andre Bachmann, Caleb Bupp, Surender Rajasekaran
  • METHODS AND COMPOSITIONS TO PREVENT AND TREAT DISORDERS ASSOCIATED WITH MUTATIONS IN THE ODC1 GENE
    Publication number: 20220331277
    Abstract: The invention provides methods for treating or preventing developmental disorders associated with mutations in the OCD1 gene.
    Type: Application
    Filed: February 2, 2022
    Publication date: October 20, 2022
    Inventors: Andre Bachmann, Caleb Bupp, Surender Rajasekaran
  • Methods and compositions to prevent and treat disorders associated with mutations in the ODC1 gene
    Patent number: 11273137
    Abstract: The invention provides methods for treating or preventing developmental disorders associated with mutations in the OCD1 gene.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: March 15, 2022
    Assignees: Board of Trustees of Michigan State University, Spectrum Health Innovations LLC
    Inventors: Andre Bachmann, Caleb Bupp, Surender Rajasekaran
  • METHODS AND COMPOSITIONS TO PREVENT AND TREAT DISORDERS ASSOCIATED WITH MUTATIONS IN THE ODC1 GENE
    Publication number: 20200215010
    Abstract: The invention provides methods for treating or preventing developmental disorders associated with mutations in the OCD1 gene.
    Type: Application
    Filed: September 4, 2019
    Publication date: July 9, 2020
    Inventors: Andre BACHMANN, Caleb Bupp, Surender Rajasekaran
  • Immunoproteasome inhibitor analogs
    Patent number: 10584105
    Abstract: The disclosure provides for compounds having immunoproteasome inhibitory activity, and pharmaceutical compositions made thereof. The disclosure further provides for the use of the compounds and compositions in treating various diseases and disorders in a subject that are associated with immunoproteasome activity, including inflammatory disorders, autoimmune disorders, hematological disorders, and neurodegenerative disorders.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: March 10, 2020
    Assignees: The Regents of the University of California, Board of Trustees of the Michigan State University
    Inventors: Michael C. Pirrung, Nicole A. Bakas, Andre Bachmann
  • IMMUNOPROTEASOME INHIBITOR ANALOGS
    Publication number: 20190047969
    Abstract: The disclosure provides for compounds having immunoproteasome inhibitory activity, and pharmaceutical compositions made thereof. The disclosure further provides for the use of the compounds and compositions in treating various diseases and disorders in a subject that are associated with immunoproteasome activity, including inflammatory disorders, autoimmune disorders, hematological disorders, and neurodegenerative disorders.
    Type: Application
    Filed: March 10, 2017
    Publication date: February 14, 2019
    Inventors: Michael C. Pirrung, Nicole A. Bakas, Andre Bachmann
  • Bioconversion reactor
    Patent number: 5091315
    Abstract: A bioconversion reactor for the anaerobic fermentation of organic material. The bioconversion reactor comprises a shell enclosing a predetermined volume, an inlet port through which a liquid stream containing organic materials enters the shell, and an outlet port through which the stream exits the shell. A series of vertical and spaced-apart baffles are positioned within the shell to force the stream to flow under and over them as it passes from the inlet to the outlet port. The baffles present a barrier to the microorganisms within the shell causing them to rise and fall within the reactor but to move horizontally at a very slow rate. Treatment detention times of one day or less are possible.
    Type: Grant
    Filed: June 13, 1989
    Date of Patent: February 25, 1992
    Assignee: The Board of Trustees of Stanford University
    Inventors: Perry L. McCarty, Andre Bachmann